As the Summer comes to an end, we wanted to give our interns an opportunity to show us what they have learned throughout their time at Crosstree. Last week, our talented interns delivered presentations and took turns pitching their "clients" to our senior banking team. We are proud of all the hard work they have put in, and are excited to see all that they do in the future. Thank you for collaborating with us this summer, and best of luck in your future endeavors! #investmentbanking #lifesciences #bankingcareers #banking
Crosstree
Investment Banking
Tampa, FL 9,480 followers
Crosstree is a global leader in health sciences M&A and Financing Advisory.
About us
Crosstree is a distinguished boutique investment banking firm focused exclusively on the needs of middle-market companies within three subsectors of the life sciences and healthcare industries: pharmaceutical services, diagnostics and tools, and digital health. Since 2004, Crosstree has advised on more completed transactions in these collective subsectors than any other investment bank. The firm provides clients a full suite of advisory and capital raising services, including both buy-and sell-side mergers and acquisitions advisory, private capital raising, strategic advisory, and valuations. Crosstree's narrow industry focus provides clients the expertise common of a bulge-bracket investment banking firm to middle-market companies and investors, with unparalleled industry insights, well-established strategic relationships across the globe and superior access to capital markets. From our offices in Tampa, Florida, Crosstree has advised clients throughout North America, Europe, India, China, Latin America, and Australia on transactions ranging from $25 million to more than $1 billion. All securities transactions are offered by and conducted through Crosstree Capital Securities, LLC, a broker-dealer registered with the SEC, a member of FINRA (www.finra.org) and SIPC (www.sipc.org), and an affiliate of Crosstree Capital Partners, Inc.
- Website
-
https://www.crosstreecapital.com/
External link for Crosstree
- Industry
- Investment Banking
- Company size
- 11-50 employees
- Headquarters
- Tampa, FL
- Type
- Privately Held
- Founded
- 2004
- Specialties
- M&A, divestiture, recapitalization, buyout, equity, merger, acquisition, life sciences, health sciences, pharma services, pharma technology, healthcare it, digital health, and laboratory services
Locations
-
Primary
5411 Skycenter Drive,
Suite 625
Tampa, FL 33607, US
Employees at Crosstree
Updates
-
🚀 New Whitepaper: "Patient Access Organizations: An Emerging Ecosystem" 🚀 In the whitepaper, we discuss how traditional clinical research sites are evolving into sophisticated Patient Access Organizations (PAOs). Read about the evolution of PAOs, market dynamics, strategic opportunities, and gain exclusive insights from industry leaders. Key Highlights: 🌏The Evolution of PAOs 📈Trends driving market growth 🤝Emerging strategic opportunities 💡Executive insights from CEOs in the industry Download the report: https://hubs.ly/Q02JBDHX0 #InvestmentBanking #MergersandAcquisitions #ClinicalResearch #PatientAccessOrganizations
-
-
Catch up on the latest insights with our Diagnostics and Tools BlueBook, designed to provide valuable perspectives for industry leaders and private equity professionals. Discover a monthly executive review that captures the essence of valuation trends, M&A developments, and transactions. Key highlights from the June 2024 edition include: 📌Moleculent closed a $26MM Series A Financing, led by Arch Venture Partners 📌RareCyte closed a $20MM Growth Financing, led by Agilent Technologies, Inc. (NYSE:A), 5AM Venture Management, Arboretum Ventures, HealthQuest Capital, Impresa Management, Forest Road Company, Sheatree Capital, Gkcc 📌BillionToOne, Inc. closed a $130MM Series D Financing, led by Premji Invest Limited Want to read more? Access the complete June 2024 edition here: https://hubs.li/Q02J57NT0 #InvestmentBanking #MergersAndAcquisitions #LifeSciences #PrivateEquity
-
-
The June 2024 edition of our Pharma Services: Drug Development BlueBook is now available. Read why C-suite executives and private equity professionals in the health sciences industries turn to our publication for valuation trends, M&A activity, and transaction reporting. Here's a glimpse into the June 2024 edition: 📌Pro-Ficiency Holdings was acquired by Simulations Plus, Inc. (NasdaqGS:SLP) 📌Integral Diagnostics Limited (ASX:IDX) announced its acquisition of Capitol Health Limited (ASX:CAJ) 📌Trialspark closed a $372MM Series A Financing, led by Sequoia Capital Operations LLC, Sanofi (ENXTPA:SAN), Andreessen Horowitz LLC, SV Angel, Thrive Capital Management, LLC, Emerson Collective, LLC, FPV Ventures, LLC Download the full June edition now: https://hubs.li/Q02J0jnW0 #Insights #MergersAndAcquisitions #PrivateEquity #FinancialNews
-
-
Celebrating #NationalInternDay! Our incredible Summer 2024 intern class comes to us representing nine different universities across the country. We are so proud of the growth all of you have made thus far. Thank you for all of your hard work and valuable contributions you have made during your time at Crosstree. Today we celebrate you! The photo below is from our Q3 Retreat earlier this month, where our 2024 interns enjoyed a fantastic evening boat cruise. Here's to many more great experiences together! #NationalInternDay #InvestmentBanking #HealthSciences Boston University University of Chicago Fairfield University University of Florida Massachusetts Institute of Technology University of Michigan University of Minnesota University of Tampa Texas A&M University
-
-
Recruiting and retaining patients for clinical trials presents a recurring challenge, particularly in Central Nervous System (CNS) trials. On top of the intricate nature of these disorders, several factors contribute to the scarcity of participants including geographical location and awareness of the trial. Kerwin Medical Center (“KMC”), located in Dallas, TX, is committed to collaborating with the local community to address CNS diseases, with a focus in Alzheimer’s Disease. With over two decades of experience in Alzheimer’s and dementia research, founder, Dr. Kerwin, has established the facility as a reputable center by facilitating community involvement in clinical trials. This reputation made KMC an ideal transaction partner for Pinnacle Clinical Research (“Pinnacle”) to help expand its partnerships in CNS research. Crosstree acted as the exclusive financial advisor to Pinnacle Clinical Research in this transaction. Read more about this #acquisition in our Deal Insights: https://hubs.li/Q02HtfB30 #pharma #pharmaceuticalindustry #mergersandacquisitions #investmentbanking Jason Layton Michael Levin
-
-
Congratulations to Pinnacle Clinical Research, a portfolio company of LongueVue Capital, on its acquisition of The Cognitive and Research Center of New Jersey, LLC, as they continue to expand their clinical trial site network and expand their CNS trial execution capabilities. To close our 134th Pharma Services transaction, and second buy-side transaction with Pinnacle this year, Crosstree helped to identify their ideal transaction partner by: 📈Evaluating a broad slate of potential strategic partners leveraging market expertise to identify the ideal transaction partner to drive future growth 💲Developing and articulating a strong value proposition which connected client capabilities with market trends to weave a compelling narrative for potential partners 🕘Streamlined deal funnel and managed the outreach process for organized and timely execution Read the full Deal Insights here: https://hubs.li/Q02H8gsG0 #pharma #pharmaceuticalindustry #mergersandacquisitions #investmentbanking #pharmaservices #clinicaltrials Jason Layton Michael Levin
-
-
We are proud to announce the appointment of our very own, Frank Harris, IV, to Vice President of Healthcare Technology. Frank, who has been a valuable member of our team since April 2021, has consistently exemplified our core values. His exceptional leadership, mentorship, and a dedication to excellence have been truly remarkable. We are looking forward to the positive impact he will have on Crosstree. Congratulations Frank! #investmentbanking #lifesciences #bankingcareers #banking
-
-
Congratulations to Pinnacle Clinical Research, a portfolio company of LongueVue Capital, on its acquisition of Kerwin Medical Center to extend their therapeutic expertise into CNS and increase their geographic reach. To close our 133rd pharma services transaction, Crosstree helped Pinnacle identify Kerwin as the ideal partner through: 📈Evaluating a broad slate of potential strategic partners leveraging market expertise to identify the ideal transaction partner to drive future growth 💲Developing and articulating a strong value proposition which connected client capabilities with market trends to weave a compelling narrative for potential partners 🕘Streamlined deal funnel and managed the outreach process for organized and timely execution Read the full Deal Insights here: https://hubs.li/Q02FKvKV0 #pharma #pharmaceuticalindustry #mergersandacquisitions #investmentbanking Jason Layton Michael Levin
-
-
Today, we proudly celebrate America's 248th birthday! At Crosstree, we extend our heartfelt wishes for a safe and joyous Independence Day filled with cherished moments among friends and family. Happy Fourth of July! #4thofJuly #IndependenceDay
-